دورية أكاديمية
PCN165 - Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
| العنوان: | PCN165 - Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada |
|---|---|
| المؤلفون: | Quon, P, Xiao, Y, Sorensen, S, Schultz, M, Tahami Monfared, AA |
| المصدر: | In Value in Health October-November 2017 20(9):A441-A442 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2017.08.248 |